Alnylam Pharmaceuticals | ALNY - هزینه PE به سود

قیمت سهام
310.60
تغییر روزانه
2.17 0.70%
ماهیانه
1.28%
سالیانه
28.36%
Q2 پیش بینی
302.85




Pe تغییر دادن تاریخ
Acadia Pharmaceuticals 11.61 2.09 2025-12
Agios Pharmaceuticals 3.56 0.68 2025-09
Alnylam Pharmaceuticals 170.7 367.33 2025-12
Amgen 25.31 15.82 2025-12
BioCryst Pharmaceuticals 6.06 1.07K 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Incyte 14.84 2.79 2025-12
Ionis Pharmaceuticals 396.15 79.28 2022-09
Moderna 27.22 14.51 2023-06
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.79 1.74 2025-12
PTC Therapeutics 9.98 3.25 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Sanofi 15.75 1.53 2025-12
Sarepta Therapeutics 27.27 0 2025-09
Takeda 235.05 184.95 2025-12
Tectonic Therapeutic 4.01 0.63 2024-03
Vertex Pharmaceuticals 26.15 2.22 2025-12
Xencor 29.92 3.22 2022-09